Skinvisible (SKVI) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.23 Bn | 627.47 Bn | 17.26 Bn | 5.11% |
| 2 | AbbVie | 443.69 Bn | 437.12 Bn | 12.70 Bn | 21.23% |
| 3 | Merck | 368.29 Bn | 361.15 Bn | 12.21 Bn | 38.72% |
| 4 | Novartis Ag | 270.18 Bn | 262.49 Bn | 11.24 Bn | 14.72% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -28.08% |
| 6 | Sanofi | 52.93 Bn | 45.55 Bn | 10.79 Bn | -36.03% |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - | - |
| 8 | Incyte | 25.21 Bn | 20.68 Bn | 1.57 Bn | 47.44% |
| 9 | United Therapeutics | 21.11 Bn | 18.44 Bn | 683.80 Mn | 12.25% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 8.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.51% |
| Mar 31, 2026 | 47.09% |
| Dec 31, 2025 | 18.98% |
| Sep 30, 2025 | 20.50% |
| Jun 30, 2025 | -4.57% |
| Mar 31, 2025 | 13.62% |
| Dec 31, 2024 | 10.63% |
| Sep 30, 2024 | -12.91% |
| Jun 30, 2024 | -4.30% |
| Mar 31, 2024 | 12.64% |
| Dec 31, 2023 | -0.63% |
| Sep 30, 2023 | 11.59% |
| Jun 30, 2023 | 4.07% |
| Mar 31, 2023 | -51.39% |
| Dec 31, 2022 | 14.08% |
| Sep 30, 2022 | 15.47% |
| Jun 30, 2022 | 39.24% |
| Mar 31, 2022 | 12.21% |
| Dec 31, 2021 | 7.55% |
| Sep 30, 2021 | -92.22% |